Se puede tomar aspirina tras una factura para ayudar a evitar los coágulos sanguíneos
JUEVES, 19 de enero de 2023 (HealthDay News) — Cuando las personas se someten a una cirugía por una fractura de brazo o de pierna, con frecuencia les inyectan anticoagulantes recetados para reducir su riesgo de desarrollar unos coágulos sanguíneos po…
Learn MoreAspirin OK After Fracture to Help Avoid Blood Clots
THURSDAY, Jan. 19, 2023 (HealthDay News) — When people undergo surgery for broken arms or legs, they are often injected with prescription blood thinners to reduce their risk of developing potentially life-threatening blood clots in their lungs and le…
Learn MoreIn Diabetes, Women Have Higher Risk for Venous Thromboembolism
THURSDAY, Jan. 5, 2023 (HealthDay News) — Individuals with diabetes mellitus (DM), especially women, have an increased risk for venous thromboembolism (VTE), according to a study published in the December issue of Diabetes Research and Clinical Pract…
Learn MoreNetwork Meta-Analysis Compares DOACs to LMWH for Cancer-Linked Thrombosis
TUESDAY, Dec. 27, 2022 (HealthDay News) — Direct oral anticoagulants (DOACs) are more effective and cost-effective than low-molecular-weight heparin for cancer-associated thrombosis (CAT), with the results sensitive to monthly drug costs, according t…
Learn MoreUnos estudios muestran que la raza y los ingresos pueden determinar los resultados en el cáncer de sangre
LUNES, 12 de diciembre de 2022 (HealthDay News) — Si alguien desarrolla un cáncer de la sangre o un coágulo sanguíneo potencialmente letal, es probable que le vaya mejor si es blanco y rico, muestran tres estudios recientes.El impacto continuo de la …
Learn MoreRace, Income Can Determine Blood Cancer Outcomes, Studies Show
MONDAY, Dec. 12, 2022 (HealthDay News) — If someone is stricken with a blood cancer or life-threatening clot, they’ll probably fare better if they are white and wealthy, three new studies show.The ongoing impact of patient race and income to medical …
Learn MoreSix Additional Weeks of Rivaroxaban Reduces Recurrent VTE
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — For patients with isolated distal deep venous thrombosis (DVT), six additional weeks of rivaroxaban after an initial six-week course of treatment reduces the risk for recurrent venous thromboembolism, accor…
Learn MoreACR: Opioids Raise Risk for VTE in Patients With Rheumatoid Arthritis
MONDAY, Nov. 21, 2022 (HealthDay News) — Opioid initiation among patients with rheumatoid arthritis (RA) is associated with similar major adverse cardiovascular events (MACE) and all-cause mortality risk versus nonsteroidal anti-inflammatory drug (NS…
Learn MorePooled Risk for Thrombocytopenia Increased After ChAdOx1-S Vaccine
THURSDAY, Oct. 27, 2022 (HealthDay News) — The risk for thrombocytopenia is increased after receipt of the ChAdOx1-S vaccine compared with BNT162b2, according to a study published online Oct. 26 in The BMJ.Xintong Li, from the University of Oxford in…
Learn MoreEndovascular Therapy Aids Outcome of Basilar-Artery Occlusion
THURSDAY, Oct. 13, 2022 (HealthDay News) — For patients with basilar-artery occlusion, a greater percentage with good functional status at 90 days is seen with endovascular thrombectomy within 12 hours after stroke, or within six and 24 hours after s…
Learn More